These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Reduction in thrombus formation by placement of endovascular stents at endarterectomy sites in baboon carotid arteries. Krupski WC; Bass A; Kelly AB; Hanson SR; Harker LA Circulation; 1991 Oct; 84(4):1749-57. PubMed ID: 1914112 [TBL] [Abstract][Full Text] [Related]
10. Lasting safe interruption of endarterectomy thrombosis by transiently infused antithrombin peptide D-Phe-Pro-ArgCH2Cl in baboons. Lumsden AB; Kelly AB; Schneider PA; Krupski WC; Dodson T; Hanson SR; Harker LA Blood; 1993 Apr; 81(7):1762-70. PubMed ID: 8461462 [TBL] [Abstract][Full Text] [Related]
11. Prolonged inhibition of acute arterial thrombosis by high dosing of a monoclonal anti-platelet glycoprotein IIb/IIIa antibody in a baboon model. Kotzé HF; Badenhorst PN; Lamprecht S; Meiring M; Van Wyk V; Nuyts K; Stassen JM; Vermylen J; Deckmyn H Thromb Haemost; 1995 Aug; 74(2):751-7. PubMed ID: 8585017 [TBL] [Abstract][Full Text] [Related]
12. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. Weiss HJ; Hawiger J; Ruggeri ZM; Turitto VT; Thiagarajan P; Hoffmann T J Clin Invest; 1989 Jan; 83(1):288-97. PubMed ID: 2910912 [TBL] [Abstract][Full Text] [Related]
13. Thrombin-induced increase in surface expression of epitopes on platelet membrane glycoprotein IIb/IIIa complex and GMP-140 is a function of platelet age. Savage B; Hunter CS; Harker LA; Woods VL; Hanson SR Blood; 1989 Aug; 74(3):1007-14. PubMed ID: 2473808 [TBL] [Abstract][Full Text] [Related]
14. Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery. Rote WE; Werns SW; Davis JH; Feigen LP; Kilgore KS; Lucchesi BR Cardiovasc Res; 1993 Mar; 27(3):500-7. PubMed ID: 8490951 [TBL] [Abstract][Full Text] [Related]
15. In vivo efficacy of SM-20302, a GP IIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood. Rebello SS; Huang J; Saito K; Lucchesi BR Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):954-60. PubMed ID: 9633937 [TBL] [Abstract][Full Text] [Related]
16. Antithrombotic effects of DMP 728, a platelet GPIIb/IIIa receptor antagonist, in a canine model of arterial thrombosis. Rote WE; Davis JH; Mousa SA; Reilly TM; Lucchesi BR J Cardiovasc Pharmacol; 1994 Apr; 23(4):681-9. PubMed ID: 7516023 [TBL] [Abstract][Full Text] [Related]
17. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956 [TBL] [Abstract][Full Text] [Related]
18. Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model. Kaplan AV; Leung LL; Leung WH; Grant GW; McDougall IR; Fischell TA Circulation; 1991 Sep; 84(3):1279-88. PubMed ID: 1832095 [TBL] [Abstract][Full Text] [Related]
19. Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogs. Kiss RG; Lu HR; Roskams T; Jang IK; Plow EF; Gold HK; Collen D Arterioscler Thromb; 1994 Mar; 14(3):367-74. PubMed ID: 8123640 [TBL] [Abstract][Full Text] [Related]
20. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis]. Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]